CVR number 32267335
Industry 962200

HOUSE OF BEAUTY ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  7.3% 5.1% 5.9% 5.1% 5.5%  
Credit score (0-100)  33 42 38 42 41  
Credit rating  BBB BBB BBB BBB BBB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales  0 0 0 0 0  
Gross profit  1,687 1,911 1,643 1,978 1,473  
EBITDA  350 697 543 1,021 551  
EBIT  331 697 543 1,021 551  
Pre-tax profit (PTP)  316.6 674.8 527.9 1,004.4 539.8  
Net earnings  245.9 525.3 408.8 779.3 418.0  
Pre-tax profit without non-rec. items  317 675 528 1,004 540  
 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  1,032 1,557 1,966 2,746 3,164  
Interest-bearing liabilities  0.0 9.1 149 150 153  
Balance sheet total (assets)  2,613 2,856 2,827 3,656 4,041  
Net Debt  -704 -1,449 -1,273 -1,134 -1,367  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  1,687 1,911 1,643 1,978 1,473  
Gross profit growth  -9.9% 13.3% -14.0% 20.4% -25.5%  
Employees  6 5 5 6 8  
Employee growth %  0.0% -16.7% 0.0% 20.0% 33.3%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  2,613 2,856 2,827 3,656 4,041  
Balance sheet change%  58.4% 9.3% -1.0% 29.3% 10.5%  
Added value  350.2 696.8 543.1 1,021.2 551.0  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -39 0 0 0 0  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 5.0 5.0 5.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  19.6% 36.5% 33.1% 51.6% 37.4%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  15.5% 25.5% 19.1% 31.5% 14.4%  
ROI %  36.4% 53.6% 29.5% 40.8% 17.8%  
ROE %  27.0% 40.6% 23.2% 33.1% 14.1%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  39.5% 54.5% 71.4% 76.6% 79.7%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -201.1% -207.9% -234.4% -111.0% -248.1%  
Gearing %  0.0% 0.6% 7.6% 5.5% 4.8%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 485.6% 19.2% 12.2% 9.3%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  1.6 2.1 3.5 4.2 4.9  
Current Ratio  1.7 2.2 3.3 4.0 4.6  
Cash and cash equivalent  704.5 1,457.7 1,422.2 1,283.8 1,519.8  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  1,032.1 1,557.4 1,966.2 2,745.5 3,163.5  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  58 139 109 170 69  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  58 139 109 170 69  
EBIT / employee  55 139 109 170 69  
Net earnings / employee  41 105 82 130 52